4//SEC Filing
Menzaghi Frederique Ph.D. 4
Accession 0001209191-23-015562
CIK 0001346830other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:36 PM ET
Size
5.6 KB
Accession
0001209191-23-015562
Insider Transaction Report
Form 4
Menzaghi Frederique Ph.D.
VP-Research & Development
Transactions
- Award
Stock Option (Right to Buy)
2023-03-01+81,000→ 81,000 totalExercise: $10.06Exp: 2033-03-01→ Common Stock (81,000 underlying)
Footnotes (1)
- [F1]The shares shall vest and become exercisable in a series of 48 successive equal monthly installments beginning on April 1, 2023, in each case subject to the Reporting Person's continued service as of each such date.
Documents
Issuer
Cara Therapeutics, Inc.
CIK 0001346830
Entity typeother
Related Parties
1- filerCIK 0001597152
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 4:36 PM ET
- Size
- 5.6 KB